HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emilce Schneeberger Selected Research

Rheumatoid Arthritis

5/2016The -308 G/A polymorphism in the tumor necrosis factor-α gene is not associated with development and progression of rheumatoid arthritis in Argentinean patients.
4/2008Clinical significance of anti-Ro antibodies in rheumatoid arthritis.
6/2004[Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emilce Schneeberger Research Topics

Disease

3Rheumatoid Arthritis
05/2016 - 06/2004
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2014 - 03/2012
1Disease Susceptibility (Diathesis)
05/2016
1Lupus Nephritis
02/2014
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
02/2014
1Xerophthalmia
04/2008
1Xerostomia
04/2008
1Disease Progression
06/2004

Drug/Important Bio-Agent (IBA)

2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2016 - 02/2014
1Plasminogen InactivatorsIBA
02/2014
1Phospholipids (Phosphatides)FDA LinkGeneric
02/2014
1Plasminogen Activators (Plasminogen Activator)IBA
02/2014
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2012
1SS-A antibodiesIBA
04/2008
1CytokinesIBA
06/2004
1AntibodiesIBA
06/2004
1Anti-Citrullinated Protein AntibodiesIBA
06/2004
1HLA-DRB1 Chains (HLA DRB1)IBA
06/2004